Terms and Conditions of Use

Get to know the guidelines for accessing and using the lumivoraquin.sbs automated recommendation platform. Your access to our services signifies agreement with these terms and ongoing compliance.

Last updated December 27, 2025

Acceptance of Terms

By creating an account, accessing our website, or receiving automated recommendations, you agree to comply with these terms and South African law. Please read these terms carefully before using the platform.

Definitions

For clarity, these terms use the following definitions:

  • Platform: The lumivoraquin.sbs web portal that processes AI-driven trading recommendations.
  • User: Any registered or unregistered individual who makes use of recommendations or features on the platform.
  • Content: All information, including recommendations, analytics, and notifications produced or posted on the platform.
  • Agreement: This contract governing platform use between the user and lumivoraquin.sbs.

Proper Use of Services

Services are intended for informational support. Users retain full responsibility for decisions and actions. No financial advice, guarantees, or warranties are provided.

Eligibility

Platform access is limited to individuals compliant with South African law and able to enter binding agreements.

Platform is not for minors or prohibited parties.

User Responsibilities

When using lumivoraquin.sbs, you must:

  • Provide accurate information for registration and ongoing updates.
  • Keep account credentials private and notify us of suspected breaches.
  • Use services only for lawful, intended purposes.
  • Respect others’ privacy, intellectual property, and local regulations.

Prohibited Activities

Do not misuse the platform. Prohibited actions include:

  • Disruption or interference with system security or other users’ activities.
  • Unauthorised access or collection of data or platform features.
  • Transmission of malware, spam, or harmful digital material.
  • Reverse engineering or misuse of platform algorithms or content.
  • Infringing on third-party rights or regulations.

Intellectual Property Rights

All Lumivoraquin content, including AI-generated recommendations, software, and site materials, remain lumivoraquin.sbs property. Copying, reusing, or distributing materials without written consent is not allowed.

User-Generated Content

You retain rights to content submitted but grant us a license to use, store, or display such information on the platform.

Your Content Rights:

You may view, update, or delete your submissions, subject to our privacy policy and legal obligations.

Privacy Commitment

Personal information is handled under our Privacy Policy, which forms part of this agreement. Please review the policy for details or updates. View Privacy Policy

Service Disclaimer

Platform outputs are informational and generated automatically.

Caution—No Guarantees:

Our recommendations are not a promise of results or outcomes. Users should independently assess suitability and risk before acting.

Limitation of Liability

Lumivoraquin.com and its affiliates will not be liable for loss, damages, or actions arising from use or reliance on information provided.

Indemnity

You agree to indemnify lumivoraquin.sbs for claims, losses, or costs resulting from rule violations or misuse of services.

Resolving Disputes

Disputes shall be handled using informal and, if needed, formal dispute resolution.

Arbitration

Disputes may be submitted to binding arbitration in South Africa, in accordance with local law and procedures.

Costs and process are outlined separately upon dispute initiation.

Online Dispute Resolution

You may also access local or international ODR mechanisms for digital service disputes.

Find out more here: Find out more here

Governing Law & Jurisdiction

South African law governs all platform terms, disputes, and use.

Termination

Lumivoraquin.com may suspend or terminate platform access for breach or inactivity with notice as required by law.

Changes

We may update these terms at our discretion. Continued use means acceptance of revisions. Review regularly for new policies.

Severability

Invalid provisions are replaced or removed without affecting the rest of this agreement.

Entire Agreement

These terms, plus supplementary policies, represent the full agreement between you and lumivoraquin.sbs.

Contact Us for Queries

Questions about these terms or reporting misuse can be sent via the channels below.

Email address: content@lumivoraquin.sbs

Phone: +27(11)7501627

Address: 155 West Street, Sandton, Johannesburg 2196 South Africa

Effective Date: From December 27, 2025 onward

Version: 1.2